WHITEHAWK THERAPEUTICS, INC. Other Nonoperating Income (Expense)
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Other Nonoperating Income (Expense) of $1.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $1.47M, a 31.16% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was $1.33M, a 98.49% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $1.64M, a 142.01% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $1.80M, a 107.61% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2025 was $93.80M, a 2390.15% increase from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2024 was $3.77M, a 38.93% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2023 was $6.17M, a 184.50% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2022 was $2.17M, a 92.03% increase from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.47M 10-Q · filed 2026-08-06 | $2.80M 10-Q · filed 2026-08-06 | $4.43M derived: sum of 3 quarters · filed 2026-08-06 | $6.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.33M 10-Q · filed 2026-05-07 | $2.96M derived: sum of 2 quarters · filed 2026-05-07 | $4.76M derived: sum of 3 quarters · filed 2026-05-07 | $6.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $3.44M derived: sum of 2 quarters · filed 2026-03-12 | $5.57M derived: sum of 3 quarters · filed 2026-08-06 | $93.80M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.80M 10-Q · filed 2025-11-06 | $3.93M derived: sum of 2 quarters · filed 2026-08-06 | $92.17M 10-Q · filed 2025-11-06 | $92.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.13M 10-Q · filed 2026-08-06 | $90.37M 10-Q · filed 2026-08-06 | $91.04M derived: sum of 3 quarters · filed 2026-08-06 | $91.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $88.23M 10-Q · filed 2026-05-07 | $88.91M derived: sum of 2 quarters · filed 2026-05-07 | $89.78M derived: sum of 3 quarters · filed 2026-05-07 | $90.78M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.54M derived: sum of 2 quarters · filed 2026-03-12 | $2.54M derived: sum of 3 quarters · filed 2026-03-12 | $3.77M 10-K · filed 2026-03-12 |
| 2024-09-30 | $867.00K 10-Q · filed 2025-11-06 | $1.87M derived: sum of 2 quarters · filed 2025-11-06 | $3.09M 10-Q · filed 2025-11-06 | $4.54M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.00M 10-Q · filed 2025-08-07 | $2.22M 10-Q · filed 2025-08-07 | $3.67M derived: sum of 3 quarters · filed 2025-08-07 | $5.22M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-08 | $2.67M derived: sum of 2 quarters · filed 2025-05-08 | $4.21M derived: sum of 3 quarters · filed 2025-05-08 | $5.79M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $2.99M derived: sum of 2 quarters · filed 2025-03-28 | $4.57M derived: sum of 3 quarters · filed 2025-03-28 | $6.17M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.55M 10-Q · filed 2024-11-06 | $3.12M derived: sum of 2 quarters · filed 2024-11-06 | $4.72M 10-Q · filed 2024-11-06 | $6.27M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $1.57M 10-Q · filed 2024-08-07 | $3.18M 10-Q · filed 2024-08-07 | $4.73M derived: sum of 3 quarters · filed 2024-08-07 | $5.29M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $1.60M 10-Q · filed 2024-05-08 | $3.15M derived: sum of 2 quarters · filed 2024-05-08 | $3.71M derived: sum of 3 quarters · filed 2024-05-08 | $3.81M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.11M derived: sum of 2 quarters · filed 2024-03-13 | $2.21M derived: sum of 3 quarters · filed 2024-03-13 | $2.17M 10-K · filed 2024-03-13 |
| 2022-09-30 | $562.00K 10-Q · filed 2023-11-08 | $662.00K derived: sum of 2 quarters · filed 2023-11-08 | $618.00K 10-Q · filed 2023-11-08 | $574.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-09 | $56.00K 10-Q · filed 2023-08-09 | $12.00K derived: sum of 3 quarters · filed 2023-08-09 | $235.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$43.00K 10-Q · filed 2023-05-10 | -$88.00K derived: sum of 2 quarters · filed 2023-05-10 | $135.00K derived: sum of 3 quarters · filed 2023-05-10 | $2.48M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $178.00K derived: sum of 2 quarters · filed 2023-03-29 | $2.52M derived: sum of 3 quarters · filed 2023-03-29 | $1.13M 10-K · filed 2023-03-29 |
| 2021-09-30 | $223.00K 10-Q · filed 2022-11-09 | $2.56M derived: sum of 2 quarters · filed 2022-11-09 | $1.17M 10-Q · filed 2022-11-09 | $792.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.34M 10-Q · filed 2022-08-10 | $952.00K 10-Q · filed 2022-08-10 | $569.00K derived: sum of 3 quarters · filed 2022-08-10 | $341.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$1.39M 10-Q · filed 2022-05-12 | -$1.77M derived: sum of 2 quarters · filed 2022-05-12 | -$2.00M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$611.00K derived: sum of 2 quarters · filed 2022-03-17 | -$927.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$228.00K 10-Q · filed 2021-11-10 | -$544.00K 10-Q · filed 2021-11-10 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $997.00 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | $997.00 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $997.00 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | $997.00 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |